Dibenzoylmorphine
From Self-sufficiency
Not to be confused with benzylmorphine.
| 220px | |
| Systematic (IUPAC) name | |
|---|---|
|
3,6-dibenzoyl-(5α,6α)-7,8-didehydro-4,5-epoxy-17-methylmorphinan | |
| Legal status | |
| Legal status |
|
| Chemical data | |
| Formula | C31H27NO5 |
| Molar mass | 493.549 g/mol[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
Dibenzoylmorphine is an opiate analogue that is a derivative of morphine. It was developed in the early 1900s after first having been synthesised in 1875 in the UK, along with various other esters of morphine, but was never used medically, instead being widely sold as one of the first "designer drugs" for around five years following the introduction of the first international restrictions on the sale of heroin in 1925. It is described as being virtually identical to heroin in its effects, and consequently was itself banned internationally in 1930 by the Health Committee of the League of Nations, in order to prevent its sale as an unscheduled alternative to heroin.[1]
See also
References
| 40px | This analgesic-related article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Articles containing unverified chemical infoboxes
- Opioids
- Benzoates
- Morphinans
- Analgesic stubs
- 2Fix
